Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer: Cochrane systematic review

Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer: Cochrane systematic review ID - 435013 BT - Cochrane Abstracts UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435013/all/Amifostine_for_salivary_glands_in_high_dose_radioactive_iodine_treated_differentiated_thyroid_cancer:_Cochrane_systematic_review DB - Evidence Central DP - Unbound Medicine ER -